Replies to post #66081 on Anavex Life Sciences Corp (AVXL)

[bas2020]

I'm afraid you're correct. Seems odd that they would file a patent for melanoma when they are pursuing an Alz treatment.

What's curious, is that if you read the original patent application it doesn't mention melanoma (that I could find). So it would seem the application was modified along the way.

Hopefully, Anavex already has an application submitted, not only for Alz, but for multiple indications. I'm anxious to hear what the company has to say.